[3O11a-2] Neurodegenerative Diseases etc

[3O11a-2-04] ROPALS TRIAL: PHASE 1/2a, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ROPINIROLE HYDROCHLORIDE FOR ALS PATIENTS BASED ON THE iPSC DRUG REPOSITIONING

〇Satoru Morimoto^1,2, Shinichi Takahashi^1,2,3, Kensuke Okada², Yugaku Daté², Daisuke Ito², Jin Nakahara², Hideyuki Okano¹ (1.Department of Physiology, Keio University School of Medicine, Tokyo, Japan, 2.Department of Neurology, Keio University School of Medicine, Tokyo, Japan, 3.Department of Neurology and Stroke, Saitama Med Univ International Medical Center)

Keywords:Amyotrophic Lateral Sclerosis (ALS), iPSC drug discovery, Ropinirole Hydrochloride, Phase 1/2a trial